ADC Therapeutics SA Ownership | Who Owns ADC Therapeutics SA?


OverviewForecastRevenueFinancialsChartTranscripts

ADC Therapeutics SA Ownership Summary


ADC Therapeutics SA is owned by 52.26% institutional investors, 21.03% insiders, and 26.71% retail investors. Redmile group is the largest institutional shareholder, holding 18.50% of ADCT shares. iShares Russell 2000 ETF is the top mutual fund, with 2.07% of its assets in ADC Therapeutics SA shares.

ADCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockADC Therapeutics SA52.26%21.03%26.71%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Redmile group15.27M18.50%$48.25M
Prosight management, lp9.57M11.59%$30.24M
Orbimed advisors4.32M5.23%$13.64M
Blackrock3.55M4.31%$11.23M
Morgan stanley2.97M3.59%$9.37M
Silverarc capital management1.77M2.14%$5.59M
Goldman sachs group1.52M1.85%$4.82M
Platinum investment management1.30M1.57%$4.10M
Bank of america corp /de/1.22M1.47%$3.84M
Artal group1.02M1.23%$3.22M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Prosight management, lp9.57M9.04%$30.24M
Redmile group15.27M2.92%$48.25M
Vantage consulting group850.74K2.00%$2.69M
Silverarc capital management1.77M1.32%$5.59M
Blue owl capital lp733.57K0.64%$2.32M
Sphera funds management685.55K0.30%$2.17M
Sectoral asset management228.10K0.29%$720.80K
Orbimed advisors4.32M0.27%$13.64M
Gcm grosvenor410.89K0.19%$1.30M
Platinum investment management1.30M0.17%$4.10M

Top Buyers

HolderShares% AssetsChange
Orbimed advisors4.32M0.27%4.32M
Blackrock3.55M0.00%3.55M
Prosight management, lp9.57M9.04%2.52M
Platinum investment management1.30M0.17%1.30M
Silverarc capital management1.77M1.32%1.27M

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp---1.00M
Monashee investment management---500.00K
Affinity asset advisors---474.74K
Atom investors lp---322.29K
Marshall wace, llp---243.24K

New Positions

HolderShares% AssetsChangeValue
Orbimed advisors4.32M0.27%4.32M$13.64M
Blackrock3.55M0.00%3.55M$11.23M
Platinum investment management1.30M0.17%1.30M$4.10M
Artal group1.02M0.08%1.02M$3.22M
State street991.30K0.00%991.30K$3.13M

Sold Out

HolderChange
Gradient investments-11.00
Federation des caisses desjardins du quebec-20.00
Global retirement partners-200.00
Group one trading-4.79K
State of wyoming-6.22K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202478-54,783,5375.76%521.33%51-10.53%1183.33%
Jun 30, 20247895.00%51,801,95149.36%623.48%57185.00%6-25.00%
Mar 31, 2024408.11%34,683,5342.21%422.49%2053.85%8-20.00%
Dec 31, 202337-13.95%33,934,788-14.00%411.76%13-27.78%10-23.08%
Sep 30, 202343-25.86%39,460,049-13.00%481.54%18-25.00%13-23.53%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF2.00M2.07%-4.49K
Biotech Growth Ord1.57M1.63%59.90K
Fidelity Small Cap Index715.85K0.74%-20.08K
iShares Russell 2000 Growth ETF432.88K0.45%-
State St Russell Sm/Mid Cp® Indx NL Cl C401.24K0.41%-
Vanguard Russell 2000 ETF369.33K0.38%-2.31K
State St Russell Sm Cap® Indx SL Cl I305.70K0.32%-
iShares Russell 2000 Value ETF303.30K0.31%-
NT R2000 Index Fund - NL197.28K0.20%197.28K
Schwab Small Cap Index194.26K0.20%27.05K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 11, 2024Redmile Group, LLC-Buy$114.00K
Dec 11, 2024Redmile Group, LLC-Buy$190.50K
Dec 11, 2024Redmile Group, LLC-Buy$190.50K
Dec 11, 2024Redmile Group, LLC-Buy$114.00K
Dec 04, 2024Redmile Group, LLC-Sell$52.48K

Insider Transactions Trends


DateBuySell
2024 Q441
2024 Q32-
2024 Q228
2024 Q120-
2010 Q4--

ADCT Ownership FAQ


Who Owns ADC Therapeutics SA?

ADC Therapeutics SA shareholders are primarily institutional investors at 52.26%, followed by 21.03% insiders and 26.71% retail investors. The average institutional ownership in ADC Therapeutics SA's industry, Biotech Stocks , is 47.04%, which ADC Therapeutics SA exceeds.

Who owns the most shares of ADC Therapeutics SA?

ADC Therapeutics SA’s largest shareholders are Redmile group (15.27M shares, 18.50%), Prosight management, lp (9.57M shares, 11.59%), and Orbimed advisors (4.32M shares, 5.23%). Together, they hold 35.32% of ADC Therapeutics SA’s total shares outstanding.

Does Blackrock own ADC Therapeutics SA?

Yes, BlackRock owns 4.31% of ADC Therapeutics SA, totaling 3.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.23M$. In the last quarter, BlackRock increased its holdings by 3.55M shares, a 100.00% change.

Who is ADC Therapeutics SA’s biggest shareholder by percentage of total assets invested?

Prosight management, lp is ADC Therapeutics SA’s biggest shareholder by percentage of total assets invested, with 9.04% of its assets in 9.57M ADC Therapeutics SA shares, valued at 30.24M$.

Who is the top mutual fund holder of ADC Therapeutics SA shares?

iShares Russell 2000 ETF is the top mutual fund holder of ADC Therapeutics SA shares, with 2.07% of its total shares outstanding invested in 2M ADC Therapeutics SA shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools